Literature DB >> 20345020

History of rotavirus research in children in Malawi: the pursuit of a killer.

Nigel Cunliffe1, Desiree Wittel, Bagrey Ngwira.   

Abstract

Rotavirus gastroenteritis is a major health problem among Malawian children. Studies spanning 20 years have described the importance, epidemiology and viral characteristics of rotavirus infections in the country. Despite a wide diversity of circulating rotavirus strains causing severe disease in young infants, a clinical trial of a human rotavirus vaccine clearly demonstrated the potential for rotavirus vaccination to greatly reduce the morbidity and mortality due to rotavirus diarrhoea in Malawi. This new enteric vaccine initiative represents a major opportunity to improve the health and survival of Malawian children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20345020      PMCID: PMC3717492          DOI: 10.4314/mmj.v21i3.45631

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  15 in total

1.  Molecular characterization of serotype G9 rotavirus strains from a global collection.

Authors:  M Ramachandran; C D Kirkwood; L Unicomb; N A Cunliffe; R L Ward; M K Bhan; H F Clark; R I Glass; J R Gentsch
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

Review 2.  Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

Authors:  Joseph S Bresee; Erik Hummelman; E A S Nelson; Roger I Glass
Journal:  J Infect Dis       Date:  2005-09-01       Impact factor: 5.226

3.  Rotavirus vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-08-10

Review 4.  Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization.

Authors:  N A Cunliffe; P E Kilgore; J S Bresee; A D Steele; N Luo; C A Hart; R I Glass
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

5.  Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.

Authors:  N A Cunliffe; J S Gondwe; S M Graham; B D Thindwa; W Dove; R L Broadhead; M E Molyneux; C A Hart
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Epidemiology of rotavirus infection in children in Blantyre, Malawi, 1997-2007.

Authors:  Nigel A Cunliffe; Bagrey M Ngwira; Winifred Dove; Benson D M Thindwa; Ann M Turner; Robin L Broadhead; Malcolm E Molyneux; C Anthony Hart
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

Review 7.  Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development.

Authors:  J R Gentsch; P A Woods; M Ramachandran; B K Das; J P Leite; A Alfieri; R Kumar; M K Bhan; R I Glass
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 8.  Rotavirus vaccines: current prospects and future challenges.

Authors:  Roger I Glass; Umesh D Parashar; Joseph S Bresee; Reina Turcios; Thea K Fischer; Marc-Alain Widdowson; Baoming Jiang; Jon R Gentsch
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

9.  Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains.

Authors:  N A Cunliffe; J S Gondwe; R L Broadhead; M E Molyneux; P A Woods; J S Bresee; R I Glass; J R Gentsch; C A Hart
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

10.  Serotype g12 rotaviruses, Lilongwe, Malawi.

Authors:  Nigel A Cunliffe; Bagrey M Ngwira; Winifred Dove; Osamu Nakagomi; Toyoko Nakagomi; Arantza Perez; C Anthony Hart; Peter N Kazembe; Charles C V Mwansambo
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more
  2 in total

1.  Fanuel Bickton talks to Desiree Witte on her clinical research experience with vaccines in Malawi.

Authors: 
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

2.  Frequency of rotavirus and adenovirus gastroenteritis among children in shiraz, iran.

Authors:  Mohammad Motamedifar; Elham Amini; Pedram Talezadeh Shirazi
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.